ArticleDrug design, development and therapy2010

Chimeric design, synthesis, and biological assays of a new nonpeptide insulin-mimetic vanadium compound to inhibit protein tyrosine phosphatase 1B.

Thomas Scior et al.PubMed ↗Full text ↗

No numbers read from the abstract.